Company overview

Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr
Founded in 2008
Little Wittenham, England, GBR
598 employees (15 in marketing)
66% recommend to a friend
61% positive business outlook

Salaries

Help build salary transparency at Immunocore

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

3 open now

Headcount trend

Company growth over the last 12 months

Headcount +9.1% year over year

Funding

Total funding

$1.2B

Last raise

$350M

Post IPO Debt, 2 years ago

Funding history

Jan 2024

Post IPO Debt Immunocore · $350M

Jul 2022

Post IPO Equity Immunocore · $140M

Jan 2021

Debt Financing Immunocore · $100M

Jan 2021

Series C Immunocore · $75M

Mar 2020

Series B Immunocore · $130M

Sep 2017

Series B Immunocore · $40M

Audience

Monthly website visitors
14.6K
Month over month+44.6%
Quarter over quarter-1.3%
Top sourceDirect (41.8%)
Ad budget per month$0.0
Average search rank43.3
Traffic source mix
Direct
41.8%
Search
40.7%
Social
8.6%
Referral
7.6%
Paid referral
1.2%

LinkedIn followers

Follower count and growth

Total followers

45.5K

12-mo growth

+32.1%

Monthly growth

+3.6%

News

Links